The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development.

Area of Science:

• Immunology
• Microbiology
• Oncology

Background:

• Chronic intestinal inflammation is linked to microbial imbalance and immune cell accumulation, increasing colorectal cancer risk.
• Myeloid-derived suppressor cells (MDSCs) are key immune cells impacting the tumor microenvironment in colitis-associated colorectal cancer (CAC).
• The precise interactions between MDSCs and dysbiotic microbiota in CAC pathogenesis are not fully understood.

Purpose of the Study:

• To investigate the intricate cross-talk between MDSCs and dysbiotic microbiota in a murine model of CAC.
• To elucidate the impact of these interactions on intestinal inflammation, immune suppression, and tumor development.
• To identify potential therapeutic strategies targeting MDSC-bacteria interactions for CAC treatment.

Main Methods:

• Utilized a murine model of colitis-associated colorectal cancer (CAC).
• Administered antibiotic treatment to disrupt MDSC-microbiota interactions.
• Analyzed changes in intestinal inflammation, MDSC levels, immune suppression, and tumor burden.
• Investigated the effects of bacteria on MDSC suppressive functions and differentiation.

Main Results:

• CAC-bearing mice showed elevated immunosuppressive MDSCs and altered microbiota composition.
• Antibiotic treatment significantly reduced intestinal inflammation, MDSC levels, and tumor burden.
• Dysbiotic microbiota were found to play a causative role in tumor development.
• Bacteria were shown to enhance MDSC suppressive activity and alter myeloid cell differentiation.

Conclusions:

• MDSC-bacteria cross-talk within the tumor microenvironment is a critical driver of CAC progression.
• Targeting MDSC-microbiota interactions offers a promising therapeutic avenue for CAC.
• Dysbiotic microbiota may serve as predictive biomarkers for tumor load in CAC.